<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(1)</volume><submitter>Yoshida H</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Large multicenter studies reporting on the association between the duration of broad-spectrum antimicrobial administration and the detection of multidrug-resistant (MDR) bacteria in the intensive care unit (ICU) are scarce. We evaluated the impact of broad-spectrum antimicrobial therapy for more than 72 h on the detection of MDR bacteria using the data from Japanese patients enrolled in the DIANA study.&lt;h4>Methods&lt;/h4>We analyzed the data of ICU patients in the DIANA study (a multicenter international observational cohort study from Japan). Patients who received empirical antimicrobials were divided into a broad-spectrum antimicrobial group and a narrow-spectrum antimicrobial group, based on whether they received broad-spectrum antimicrobials for more or less than 72 h, </pubmed_abstract><journal>Antimicrobial resistance and infection control</journal><pagination>119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9520832</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Use of broad-spectrum antimicrobials for more than 72 h and the detection of multidrug-resistant bacteria in Japanese intensive care units: a multicenter retrospective cohort study.</pubmed_title><pmcid>PMC9520832</pmcid><pubmed_authors>Suzuki T</pubmed_authors><pubmed_authors>Kida Y</pubmed_authors><pubmed_authors>Katayama S</pubmed_authors><pubmed_authors>Fujitani S</pubmed_authors><pubmed_authors>Kameda S</pubmed_authors><pubmed_authors>Nashiki H</pubmed_authors><pubmed_authors>Shibata M</pubmed_authors><pubmed_authors>Kawagishi T</pubmed_authors><pubmed_authors>Kobayashi A</pubmed_authors><pubmed_authors>De Bus L</pubmed_authors><pubmed_authors>Hashimoto S</pubmed_authors><pubmed_authors>Hashimoto H</pubmed_authors><pubmed_authors>Tanaka C</pubmed_authors><pubmed_authors>Motohashi T</pubmed_authors><pubmed_authors>Hara Y</pubmed_authors><pubmed_authors>DIANA Study Japanese group</pubmed_authors><pubmed_authors>Inoue M</pubmed_authors><pubmed_authors>Yoshida H</pubmed_authors><pubmed_authors>Shindo S</pubmed_authors><pubmed_authors>Hashi H</pubmed_authors><pubmed_authors>Komuro T</pubmed_authors><pubmed_authors>Kanamoto M</pubmed_authors><pubmed_authors>De Waele J</pubmed_authors><pubmed_authors>Kawano Y</pubmed_authors><pubmed_authors>Takaba A</pubmed_authors><pubmed_authors>Fujiwara S</pubmed_authors><pubmed_authors>Kuriyama A</pubmed_authors><pubmed_authors>Fujita Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Use of broad-spectrum antimicrobials for more than 72 h and the detection of multidrug-resistant bacteria in Japanese intensive care units: a multicenter retrospective cohort study.</name><description>&lt;h4>Background&lt;/h4>Large multicenter studies reporting on the association between the duration of broad-spectrum antimicrobial administration and the detection of multidrug-resistant (MDR) bacteria in the intensive care unit (ICU) are scarce. We evaluated the impact of broad-spectrum antimicrobial therapy for more than 72 h on the detection of MDR bacteria using the data from Japanese patients enrolled in the DIANA study.&lt;h4>Methods&lt;/h4>We analyzed the data of ICU patients in the DIANA study (a multicenter international observational cohort study from Japan). Patients who received empirical antimicrobials were divided into a broad-spectrum antimicrobial group and a narrow-spectrum antimicrobial group, based on whether they received broad-spectrum antimicrobials for more or less than 72 h, </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2026-05-27T19:12:30.137Z</modification><creation>2025-05-18T12:49:08.983Z</creation></dates><accession>S-EPMC9520832</accession><cross_references><pubmed>36175948</pubmed><doi>10.1186/s13756-022-01146-3</doi></cross_references></HashMap>